Omics Playground

Omics Playground is a cloud-based, no-code analytics platform for omics data interpretation, developed by BigOmics Analytics (founded 2018, Lugano, Switzerland).

Reviewed by 7wData

On this page

Publisher review

Omics Playground is a cloud-based, no-code analytics platform for omics data interpretation, developed by BigOmics Analytics (founded 2018, Lugano, Switzerland). It bridges the gap between raw sequencing output and biological insight by offering 18+ analysis modules—differential expression, gene set enrichment, biomarker discovery, survival analysis, CNV detection, and network analysis—without requiring programming. The platform provides 150+ interactive visualizations (volcano plots, heatmaps, KEGG pathway overlays, UMAP, PCA) and integrates 50,000+ gene sets and 30,000+ drug profiles.

It supports bulk RNA-seq, single-cell RNA-seq, microarray, proteomics (LC-MS/MS), and metabolomics data in human and mouse models, with multi-omics integration via MOFA. The interface is graphical and interactive; users upload raw counts or normalized matrices, select analysis workflows, and generate publication-ready outputs without command-line work. BigOmics claims 82% faster analysis compared to manual pipelines and reports 92% time savings.

The platform is deployed as SaaS on their cloud instance, Docker containers for on-premises use, or embedded in partner workflows (Seqera Studios, DNAnexus, Lexogen). Academic use is free with restricted trial resources (3 comparisons, 20 samples max, no expiration). Industry pricing is custom; the company cites 8× return on investment.

Peer-reviewed validation exists (NAR Genomics and Bioinformatics, 2020). Customer base includes 50+ biotech/pharma firms and academic partners at Harvard and Oxford.

Get the AI & data signal, daily.

335k+ subscribers read this every morning. One email, both newsletters. Unsubscribe anytime.

How it works

  1. Differential Expression Analysis

    Seven methods (limma, edgeR, DESeq2, MAST, SCDE, Monocle, VAM) to identify genes with significant expression changes across conditions, with integrated volcano plot and heatmap outputs.

  2. Gene Set Enrichment Analysis (GSEA)

    Seven GSEA approaches to detect enriched biological pathways and gene ontologies, integrated with 50,000+ curated gene sets and KEGG/Reactome pathway databases for functional interpretation.

  3. Biomarker Discovery

    Machine-learning pipeline using LASSO, random forests, and XGBoost to identify and rank candidate biomarkers, with survival-stratification validation on user-provided clinical metadata.

  4. Multi-Omics Integration

    Combines RNA-seq, proteomics, and metabolomics datasets through MOFA and MixOmics to reveal cross-modal associations and latent factors driving phenotype variation.

  5. 150+ Interactive Plots

    Real-time, brush-and-click visualizations including heatmaps, volcano plots, PCA, UMAP, survival curves, network graphs, and KEGG pathway overlays; export to PDF or PNG.

  6. Cloud-Based No-Code Interface

    Graphical UI with drag-and-drop workflows, parameter presets, and one-click analysis; no CLI or programming required; cloud SaaS, Docker, or on-premises deployment options.

  7. Clustering and Network Analysis

    Unsupervised clustering (k-means, hierarchical, DBSCAN), single-cell clustering (Seurat pipeline), and protein/pathway interaction networks with force-directed layout visualization.

Strengths and trade-offs

Strengths

  • Eliminates need for scripting; designed for lab biologists without bioinformatics training. Peer-reviewed (NAR, 2020) with 50+ pharma/biotech customers including Merck and Sanofi.
  • 18+ analysis modules and 150+ interactive plots reduce analysis time by 82–92% vs. manual pipelines, with published 8× ROI claim for industry use.
  • Multi-omics integration (RNA + proteomics + metabolomics) via MOFA, plus 30,000+ drug profiles and 50,000+ gene sets; single-cell RNA-seq (scRNA-seq) support with Seurat pipeline.

Trade-offs

  • Data upload speed is slow for large datasets (100M+ reads); users report 30+ min uploads, limiting real-time exploratory analysis; Docker/on-premises option available but requires DevOps overhead.
  • Report and visualization customization less flexible than code-based (R/Python) pipelines; UI-driven workflows constrain advanced or novel analyses; export is PDF/PNG, not raw tables.
  • Cloud-dependent SaaS model creates vendor lock-in and data residency concerns; species support limited to human and mouse (bacterial omics listed as 'in development'); 1-hour session timeout on trial tier.

Pricing context

Omics Playground uses a custom-quote commercial model with no public pricing. Free academic trial offers 3 comparisons, 4 datasets, 20 samples maximum, with no expiration; users report the trial is sufficient for small projects but restricted for production use. Industry tiers (Pro, Enterprise, Ultimate) are available via sales contact; the company claims 8× ROI and 92% time savings for paid customers but does not publish per-seat or per-dataset rates.

Deployment options (SaaS cloud, Docker, on-premises) may affect pricing. BigOmics has raised $4.63M+ across three funding rounds, positioning itself as a premium no-code tool for biotech/pharma.

User reviews

No user reviews yet. Be the first to write one.

Sources

Reporting on this tool draws on these publicly available sources.

  1. bigomics.ch — Official product page; describes features, deployment models (SaaS, Docker), target use cases (RNA-seq, biomarker discovery, multi-omics), and claims 82% faster analysis, 92% time savings, 8x ROI.
  2. github.com — Open-source GitHub repository with 130+ stars, v4.1.8 current version, active development; confirms R implementation, 18+ analysis modules, 150+ plot types, integration with 50,000+ gene sets.
  3. playground.bigomics.ch — Live SaaS instance; allows verification of UI, free trial access (3 comparisons, 20 samples max, no expiration), and confirmation of supported data types (RNA-seq, proteomics, metabolomics).
  4. academic.oup.com — Peer-reviewed publication in NAR Genomics and Bioinformatics (March 2020); validation of features, benchmarks, and academic credibility; DOI 10.1093/nargab/lqaa007.
  5. www.g2.com — G2 reviews: 5.0/5 rating, verified customer quote ('95% of analysis in 15% of previous time'), third-party validation of claimed time savings.
  6. www.crunchbase.com — Company founding year (2018), HQ location (Lugano, Switzerland), funding rounds ($4.63M+), and key customers (Merck, Sanofi, Vertex, AbbVie, Harvard, Oxford).